Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 8, 2026, Red Cat Holdings, Inc. (RCAT) has a Wall Street consensus price target of $17.00, based on estimates from 2 covering analysts. With the stock currently trading at $10.36, this represents a potential upside of +64.1%. The company has a market capitalization of $1.02B.
Analyst price targets range from a low of $12.00 to a high of $22.00, representing a 59% spread in expectations. The median target of $17.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, RCAT trades at a trailing P/E of -17.3x. Analysts expect EPS to grow -21.9% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonQuick answers to the most common questions about buying RCAT stock.
The consensus Wall Street price target for RCAT is $17, representing 64.1% upside from the current price of $10.36. With 2 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
RCAT has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $17 implies 64.1% upside from current levels.
RCAT's current price is $10.36 with a consensus target of $17 (64.1% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $22 for RCAT, while the most conservative target is $12. The consensus of $17 represents the median expectation. These targets typically reflect 12-month expectations.
RCAT is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month RCAT stock forecast based on 2 Wall Street analysts shows a consensus price target of $17, with estimates ranging from $12 (bear case) to $22 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on RCAT, with a "Buy" consensus rating and $17 price target (64.1% upside). 2 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
RCAT analyst price targets range from $12 to $22, a 59% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $17 consensus represents the middle ground.